On today’s news release on the GerPang website; So GP is basically Getting China (FDA equivalent) approval for IHT BioScan device leasing that already has US FDA Approval and in return gets exclusivity for the product in China. http://www.gerpanghealthcare.com/news.html (may not work on mobile).
So GP is basically Getting China (FDA equivalent) approval for IHT and in return gets exclusivity for the product in China.